Sign up for free insights newsletter
CL

Clariane SE

CLARIEuronext Paris

Need professional-grade analysis? Visit stockanalysis.com

€3.50
-3.26%
End of day
Market Cap

$1.45B

P/E Ratio

N/A

Employees

65,000

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.75-0.77-0.34-0.64-0.60
Calmar-1.97-0.86-0.34-0.28-0.73
Sharpe-0.54-0.59-0.24-0.44-0.44
Omega0.920.921.000.960.95
Martin-5.28-1.36-0.59-0.37-1.53
Ulcer4.1518.8821.9071.9132.77

Clariane SE (CLARI) Price Performance

Clariane SE (CLARI) trades on Euronext Paris in EUR. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at EUR3.50, down 3.26% from the previous close.

Over the past year, CLARI has traded between a low of EUR3.32 and a high of EUR5.36. The stock has lost 21.9% over this period. It is currently 34.7% below its 52-week high.

Clariane SE has a market capitalization of $1.45B.

About Clariane SE

Clariane SE provides care home, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. The company operates long-term care and short stays nursing homes. It also provides diagnosis outpatient programs; healthcare services comprising medical and full hospitalization services, as well as day hospitalisation and consultations; and operates post-acute and rehabilitation care facilities, mental healthcare clinics, hospital home care networks, and home community nursing facilities. In addition, the company offers home care and hospital home care services; and assisted living residences or shared housing. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France.

Company Info

Exchange
Euronext Paris
Currency
EUR
Country
France

Financial Metrics

Revenue (TTM)
$5.31B
EBITDA
$616.68M
Profit Margin
-1.16%
EPS (TTM)
-0.03
Book Value
10.08

Technical Indicators

52 Week High
€5.51
52 Week Low
€2.94
50 Day MA
€3.87
200 Day MA
€4.17
Beta
0.71

Valuation

Trailing P/E
N/A
Forward P/E
36.10
Price/Sales
0.27
Price/Book
0.40
Enterprise Value
$8.91B